Compounds > beta-lactams
Page last updated: 2024-09-04

beta-lactams and Disease Exacerbation

beta-lactams has been researched along with Disease Exacerbation in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's6 (66.67)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Baalbaki, N; Giuliano, C; Hartner, CL; Johnson, L; Kale-Pradhan, P1
Deshmukh, R; Kumari, S1
Deka, R; Hong, LT; King, JB; Liou, TG; Stevens, V; Young, DC1
Beumier, M; Casu, GS; Cotton, F; Hites, M; Jacobs, F; Taccone, FS; Vincent, JL; Wolff, F1
Adak, GK; Byrne, L; Charlett, A; Harker, K; Jenkins, C; Launders, N1
Ampofo, K; Cash, J; Chatfield, BA; Marshall, BC; Olson, J; Waters, CD; Young, DC; Zobell, JT1
Bados-Albiero, A; De Blic, J; Delacourt, C; Karila, C; Le Bourgeois, M; Perrin, Y; Ponvert, C; Scheinmann, P1
Jain, M; Prickett, M1
Devreese, K; Leus, B; Malfait, R; van den Bossche, J1

Reviews

1 review(s) available for beta-lactams and Disease Exacerbation

ArticleYear
β-lactam antibiotics to tame down molecular pathways of Alzheimer's disease.
    European journal of pharmacology, 2021, Mar-15, Volume: 895

    Topics: Alzheimer Disease; Animals; Anti-Bacterial Agents; beta-Lactams; Brain; Disease Progression; Drug Repositioning; Humans; Nerve Degeneration; Neuroprotective Agents; Signal Transduction

2021

Other Studies

8 other study(ies) available for beta-lactams and Disease Exacerbation

ArticleYear
Azithromycin Versus Beta-lactams in Hospitalized Patients with Acute Exacerbations of COPD.
    Journal of general internal medicine, 2022, Volume: 37, Issue:16

    Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Disease Progression; Humans; Pulmonary Disease, Chronic Obstructive; Retrospective Studies

2022
Pharmacokinetics of Continuous Infusion Beta-lactams in the Treatment of Acute Pulmonary Exacerbations in Adult Patients With Cystic Fibrosis.
    Chest, 2018, Volume: 154, Issue:5

    Topics: Adult; Anti-Bacterial Agents; beta-Lactams; Cystic Fibrosis; Disease Progression; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; Retrospective Studies; Symptom Flare Up; Tobramycin

2018
Elevated β-lactam concentrations associated with neurological deterioration in ICU septic patients.
    Minerva anestesiologica, 2015, Volume: 81, Issue:5

    Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Critical Care; Critical Illness; Disease Progression; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Nervous System Diseases; Pseudomonas aeruginosa; Retrospective Studies; Sepsis

2015
Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009-2012.
    BMJ open, 2016, Jan-29, Volume: 6, Issue:1

    Topics: Adolescent; Adult; Age of Onset; Aged; Anti-Bacterial Agents; beta-Lactams; Child; Child, Preschool; Disease Progression; England; Escherichia coli Infections; Female; Hemolytic-Uremic Syndrome; Humans; Incidence; Infant; Male; Middle Aged; Population Surveillance; Retrospective Studies; Risk Factors; Severity of Illness Index; Shiga-Toxigenic Escherichia coli; Young Adult

2016
A survey of the utilization of anti-pseudomonal beta-lactam therapy in cystic fibrosis patients.
    Pediatric pulmonology, 2011, Volume: 46, Issue:10

    Topics: Anti-Bacterial Agents; beta-Lactams; Cross-Sectional Studies; Cystic Fibrosis; Data Collection; Disease Progression; Drug Utilization; Humans; Pseudomonas

2011
Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests.
    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2011, Volume: 22, Issue:4

    Topics: Adolescent; beta-Lactams; Child; Child, Preschool; Disease Progression; Drug Hypersensitivity; Exanthema; Humans; Hypersensitivity, Delayed; Hypersensitivity, Immediate; Infant; Practice Guidelines as Topic; Predictive Value of Tests; Prevalence; Prognosis; Risk Factors; Skin Tests; Stevens-Johnson Syndrome

2011
Efficacy of β-lactams as single agents for treating severe pulmonary exacerbations during pregnancy in cystic fibrosis.
    American journal of respiratory and critical care medicine, 2012, Dec-15, Volume: 186, Issue:12

    Topics: Administration, Intravenous; Aminoglycosides; Anti-Bacterial Agents; beta-Lactams; Contraindications; Cystic Fibrosis; Disease Progression; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Pseudomonas Infections; Treatment Outcome

2012
Factor V inhibitor: case report.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2006, Volume: 17, Issue:7

    Topics: Aged; Anti-Bacterial Agents; beta-Lactams; Blood Coagulation Tests; Ciprofloxacin; Disease Progression; Factor V; Humans; Immunosuppressive Agents; Intracranial Hemorrhages; Lung Diseases; Male; Postoperative Complications

2006